Testing effectiveness (Phase 2)Study completedNCT00017212What this trial is testingDX-8951f in Treating Patients With Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Daiichi Sankyo
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Not applicableUnknownNCT04440605What this trial is testingConfirm the Accuracy of Locally Advanced Gastric Cancer DiagnosisWho this might be right forGastric CancerGastric Cancer StageCT+1 more Peking University 968
Not applicableLooking for participantsNCT06902545What this trial is testingObserve the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.Who this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Korea, Inc.
Early research (Phase 1)Study completedNCT01576666What this trial is testingPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsWho this might be right forDose EscalationSafetyPreliminary Efficacy+9 more Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581405What this trial is testingGI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric CancerWho this might be right forGastric AdenocarcinomaGastric Cancer University of Illinois at Chicago 26
Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT04997837What this trial is testingStudy of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaWho this might be right forGastric Cancer Fudan University 433
Testing effectiveness (Phase 2)Study completedNCT00054457What this trial is testingDocetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Study completedNCT05104567What this trial is testingSAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)Who this might be right forOesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more Sanofi 138
Early research (Phase 1)Study completedNCT05262556What this trial is testingNP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine CarcinomasWho this might be right forGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine NeoplasmNeuroendocrine Carcinoma+1 more Amr Mohamed MD 15
Not applicableStudy completedNCT07034495What this trial is testingLaparotomy, Laparoscopy, da Vinci SystemWho this might be right forStomach NeoplasmsPancreatic NeoplasmsLiver Neoplasms+5 more National Chung Hsing University 486
Testing effectiveness (Phase 2)UnknownNCT03400592What this trial is testingStudy of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric AdenocarcinomaWho this might be right forStomach Neoplasms Peking University 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818070What this trial is testingA Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal AdenocarcinomaWho this might be right forGastric CancerEsophagogastric Junction CancerEsophageal Adenocarcinoma Ono Pharmaceutical Co., Ltd. 600
Early research (Phase 1)Study completedNCT02960594What this trial is testingHTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of RelapseWho this might be right forBreast CancerLung CancerPancreatic Cancer+6 more Inovio Pharmaceuticals 93
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07655661What this trial is testingMannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.Who this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Ming Liu 52
Testing effectiveness (Phase 2)Looking for participantsNCT07546812What this trial is testingStudy of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal AdenocarcinomasWho this might be right forHER2-negativeGastroesophageal JunctionEsophageal Adenocarcinoma+1 more Gilead Sciences 120
Testing effectiveness (Phase 2)Study completedNCT00447330What this trial is testingOxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaWho this might be right forEsophageal NeoplasmsStomach NeoplasmsNeoplasm Metastasis Duke University 60
Testing effectiveness (Phase 2)UnknownNCT00674167What this trial is testingThe Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaWho this might be right forGastric Cancer National University Hospital, Singapore 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06374901What this trial is testingTislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.Who this might be right forGastric Cancer Xiangdong Cheng 134